Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential expression of the G-protein-coupled formyl Peptide receptor in melanoma associates with aggressive phenotype.

The American Journal of dermatopathology - 1 Apr 2013

Chakravarti Nitin, Peddareddigari Vijay G R, Warneke Carla L, Johnson Marcella M, Overwijk Willem W, Hwu Patrick, Prieto Victor G

Abstract excerpt

Melanoma, due to its metastatic rate, is among the most aggressive forms of skin cancer. Human formyl peptide receptor (FPR) and its variant FPR-like 1 (FPRL1) have been associated with cell migration and invasiveness in neoplasms. We have studied the in situ expression of these receptors in a large series of melanocytic lesions and correlated the expression with clinicopathological features and prognosis. Tissue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Melanoma

Share to Phenotype

Share to Skin Neoplasms

Share to Tissue Array Analysis

Source

Identifiers

PMID: 23147350
DOI: 10.1097/DAD.0b013e31825b2506

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential expression of the G-protein-coupled formyl Peptide receptor in melanoma associates with aggressive phenotype.PMID 23147350Read ↗

G‐protein‐coupled receptors and melanomaSemantic proximity Read ↗

Quantitative expression profiling of G‐protein‐coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug targetSemantic proximity Read ↗

Functional interplay between secreted ligands and receptors in melanoma.Semantic proximity Read ↗

Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma.Semantic proximity Read ↗

Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.Semantic proximity Read ↗

Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathwaysSemantic proximity Read ↗

Malignant melanoma and melanocortin 1 receptorSemantic proximity Read ↗

ROR2 Promotes EMT and Necrosis by Hyperactivating ERK in MelanomaSemantic proximity Read ↗

Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.Semantic proximity Read ↗

Expression and function of the AMF receptor by human melanoma in experimental and clinical systems.Semantic proximity Read ↗

Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.Semantic proximity Read ↗

Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.